| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.09 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.098 | 0.09 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |